Mesenchymal Stem Cells Market revenue to surpass USD 17 Billion by 2035, says Research Nester
11 juil. 2023 06h50 HE
|
Research Nester
New York, July 11, 2023 (GLOBE NEWSWIRE) -- The global mesenchymal stem cells market is slated to grow at a CAGR of ~14% between 2023 and 2035. The market is estimated to garner a revenue of ~USD 17...
Global Cell Isolation/Cell Separation Market Report 2023: Growing Focus on Personalized Medicine Fuels the Sector
09 juin 2023 06h58 HE
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose...
Global $15.52 Bn Cell Isolation (Human Cells and Animal Cells) Markets, Competition Forecast & Opportunities, 2026
18 juin 2021 06h13 HE
|
Research and Markets
Dublin, June 18, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Isolation Market By Product (Consumables and Instruments), By Cell Type (Human Cells and Animal Cells), By Source, By Technique, By...
American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
02 juil. 2014 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
18 juin 2014 09h00 HE
|
American CryoStem Corp.
EATONTOWN, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem and Rutgers University File Joint Patent on Adipose-Derived Stem Cell Platform Technology
10 avr. 2014 08h00 HE
|
American CryoStem Corp.
Combined Technologies Create Basis for Joint Development of
Multi-Functional Nanotechnology Platforms
EATONTOWN, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation...
American CryoStem Posts Letter to Shareholders
06 janv. 2014 13h45 HE
|
American CryoStem Corp.
EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented...
American CryoStem and Protein Genomics Form Autogenesis Corporation to Support Development of Unique Stem Cell-Based Wound Products
14 nov. 2013 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Opens Adipose Tissue Collection Centers at Dr. Park Avenue Cosmetic Surgery Clinics Across New Jersey
25 sept. 2013 08h57 HE
|
American CryoStem Corp.
EATONTOWN, N.J., Sept. 25, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
10 juil. 2013 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., July 10, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...